With 6.56 million shares changed hands, the volume of the stock remained lighter than its average volume of 13.42 million shares. The 52-week range on CVS shows that it touched its highest point at $80.75 and its lowest point at $43.56 during that stretch. It currently has a 1-year price target of $71.39. With its current market cap of 80.51 billion, CVS has annualized dividend of $2.66 while the current yield stands at 4.17%. Beta for the stock currently stands at 0.54.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CVS was down-trending over the past week, with a drop of -3.83%, but this was up by 13.63% over a month. Three-month performance surged to 11.84% while six-month performance rose 8.70%. The stock lost -17.28% in the past year, while it has gained 42.26% so far this year. A look at the trailing 12-month EPS for CVS yields 3.66 with Next year EPS estimates of 6.88. For the next quarter, that number is 1.57. This implies an EPS growth rate of 8.67% for this year and 16.80% for next year. EPS is expected to grow by 13.71% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -6.37%.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CVS since 20 analysts follow the stock currently. There are 14 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 6 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $5.34259 being high and $4.68227 being low. For CVS, this leads to a yearly average estimate of $5.14249. Based on analyst estimates, the high estimate for the next quarter is $1.8 and the low estimate is $1.26. The average estimate for the next quarter is thus $1.59.
